Feeding Trial in the Obese Critical Care Population
Completed
- Conditions
- Critical IllnessObesity
- Interventions
- Other: enteral formula
- Registration Number
- NCT01357200
- Lead Sponsor
- Société des Produits Nestlé (SPN)
- Brief Summary
This study will assess enteral feeding in an obese critically ill population with a higher protein whey based peptide formula.
- Detailed Description
Assess enteral feeding goal with a higher protein whey based peptide formula in an obese critically ill population.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
- Age ≥ 18 years
- Surgical or Medical intensive care unit (ICU) patient
- Body mass index (BMI) ≥ 30
Exclusion Criteria
- pregnant or lactating
- unable to access gastrointestinal (GI) tract for feeding via tube
- other contraindication to tube feeding
- admitted with burns
- severe head trauma
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description critically ill obese adults enteral formula Age ≥ 18 years, body mass index (BMI) ≥ 30, in intensive care unit (ICU) requiring tube feeding ≥ 3 days
- Primary Outcome Measures
Name Time Method time to feeding goal achievement up to 5 days on all participants
- Secondary Outcome Measures
Name Time Method gastrointestinal measures assessment daily for up to 11 days on all participants
percent of nutrition goal met up to 5 days on all participants
assessment of frequency and nature of adverse events daily for up to 11 days on all participants
serum biochemical markers assessment daily for up to 11 days on all participants
Trial Locations
- Locations (2)
University of Kentucky
🇺🇸Lexington, Kentucky, United States
University of Louisville
🇺🇸Louisville, Kentucky, United States